Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Bratislava S.E. Other stock markets 15/06/2026			5-day change	1st Jan Change
31.00 ^EUR	0.00%		0.00%	+3.33%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 213M 196M 183M 345M 22.98B 353M 2.36B 913M 11.34B 913M 893M 39.36B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 212M 196M 183M 344M 22.9B 352M 2.36B 910M 11.3B 910M 890M 39.23B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Zentiva announces sale from Advent to GTCR	RE
11/09/25	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
11/09/25	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
11/09/25	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
21/02/13	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

3 months	+3.33%
6 months	+3.33%
Current year	+3.33%

Zentiva, Share Price

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news : Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Course Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

1 month	30	31
Current year	29	33
1 year	29	45
3 years	24	45
5 years	11	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	11/11/2015
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	17/08/2022

Director	Title	Age	Since
Mojmír Krutý BRD	Director/Board Member	-	07/07/2013
Martin Albert BRD	Director/Board Member	-	17/10/2018
Kenneth Lynard BRD	Director/Board Member	58	14/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	0.00%	0.00%	+3.33%	+3.33%	57.36M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.71%	-0.34%	+11.10%	+77.03%	47.58B
OTSUKA HOLDINGS CO., LTD.	-0.96%	+0.89%	+51.10%	+104.99%	35.47B
CIPLA LIMITED	+0.65%	+2.19%	-2.75%	+44.29%	12.42B
ZYDUS LIFESCIENCES LIMITED	-0.90%	-0.03%	+12.32%	+90.70%	11.83B
KRKA, D. D.	+2.46%	-2.31%	+32.29%	+118.03%	8.79B
GEDEON RICHTER	+1.24%	+2.60%	+22.40%	+45.37%	7.09B
ONO PHARMACEUTICAL CO., LTD.	-0.91%	+2.53%	+53.18%	-8.37%	6.99B
GLENMARK PHARMACEUTICALS LIMITED	+0.72%	+1.07%	+25.60%	+225.84%	6.53B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+9.12%	+6.89%	-29.64%	+6.47%	5.4B
Average	+1.10%	+1.76%	+17.89%	+70.77%	14.22B
Weighted average by Cap.	+0.08%	+1.73%	+23.03%	+83.17%

	2017	2018
Net sales	143M 125M 115M 108M 203M 13.49B 207M 1.39B 536M 6.65B 536M 524M 23.11B	36.17M 31.67M 29.24M 27.31M 51.4M 3.42B 52.57M 352M 136M 1.69B 136M 133M 5.86B
Net income	77.98M 68.28M 63.03M 58.86M 111M 7.37B 113M 758M 293M 3.64B 293M 286M 12.63B	2.29M 2.01M 1.85M 1.73M 3.25M 217M 3.33M 22.28M 8.6M 107M 8.6M 8.41M 371M
Net Debt	-0.09 -0.08 -0.07 -0.07 -0.13 -8.7 -0.13 -0.89 -0.35 -4.29 -0.35 -0.34 -14.9	-0.77 -0.68 -0.63 -0.58 -1.1 -73.18 -1.12 -7.53 -2.91 -36.1 -2.91 -2.84 -125.34